Overview

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of novel products for the treatment of...

Open

$16.28

Prior close

$16.10

Today's high

$16.44

Today's low

$15.86

52 Week high

$39.89

52 Week low

$12.73

News

GlobeNewsWire • 6 days ago • RARE

Ultragenyx to Host Conference Call for Third Quarter 2026 Financial Results and Corporate Update

Zacks Investment Research • 6 days ago • RARE

Ultragenyx (RARE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Zacks Investment Research • 19 days ago • RARE

Can RARE's Approved Product Portfolio Drive Its Next Growth Phase?

GlobeNewsWire • 20 days ago • RARE

Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $203 Million

Zacks Investment Research • 25 days ago • RARE

Ultragenyx to Sell Rare Pediatric Disease PRV for $210M to Boost Cash